ID   ECE1_RAT                Reviewed;         762 AA.
AC   P42893; Q9WUY8; Q9WUY9;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   24-JUL-2024, entry version 166.
DE   RecName: Full=Endothelin-converting enzyme 1;
DE            Short=ECE-1;
DE            EC=3.4.24.71;
GN   Name=Ece1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C).
RC   TISSUE=Endothelial cell;
RX   PubMed=8034569; DOI=10.1016/s0021-9258(17)32298-6;
RA   Shimada K., Takahashi M., Tanzawa K.;
RT   "Cloning and functional expression of endothelin-converting enzyme from rat
RT   endothelial cells.";
RL   J. Biol. Chem. 269:18275-18278(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-116, ALTERNATIVE SPLICING, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Smooth muscle;
RX   PubMed=10491078; DOI=10.1046/j.1432-1327.1999.00602.x;
RA   Valdenaire O., Lepailleur-Enouf D., Egidy G., Thouard A., Barret A.,
RA   Vranckx R., Tougard C., Michel J.-B.;
RT   "A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from
RT   an additional promoter.";
RL   Eur. J. Biochem. 264:341-349(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-109 (ISOFORM A).
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RX   PubMed=7672114; DOI=10.1016/0014-5793(95)00886-e;
RA   Shimada K., Takahashi M., Ikeda M., Tanzawa K.;
RT   "Identification and characterization of two isoforms of an endothelin-
RT   converting enzyme-1.";
RL   FEBS Lett. 371:140-144(1995).
RN   [4]
RP   SUBUNIT, SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-420; GLU-600; GLU-659
RP   AND HIS-724.
RX   PubMed=8645169; DOI=10.1042/bj3150863;
RA   Shimada K., Takahashi M., Turner A.J., Tanzawa K.;
RT   "Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a
RT   similar catalytic mechanism and a distinct substrate binding mechanism
RT   compared with neutral endopeptidase-24.11.";
RL   Biochem. J. 315:863-867(1996).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Converts big endothelin-1 to endothelin-1.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolysis of the 21-Trp-|-Val-22 bond in big endothelin to
CC         form endothelin 1.; EC=3.4.24.71;
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: Inhibited by phosphoramidon. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:8645169). Interacts with
CC       PPP1R16B (By similarity). Interacts with TSPAN8; this interaction
CC       recruits the endothelin converting enzyme ECE1 to tetraspanin-enriched
CC       microdomains and positively modulates its enzymatic activity (By
CC       similarity). {ECO:0000250|UniProtKB:P42891,
CC       ECO:0000269|PubMed:8645169}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10491078,
CC       ECO:0000269|PubMed:8645169}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:10491078, ECO:0000269|PubMed:8645169}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=A;
CC         IsoId=P42893-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=P42893-2; Sequence=VSP_005505;
CC       Name=C;
CC         IsoId=P42893-3; Sequence=VSP_005506;
CC       Name=D;
CC         IsoId=P42893-4; Sequence=VSP_005507;
CC   -!- TISSUE SPECIFICITY: All isoforms are expressed in aortic endothelial
CC       cells. Isoform A is also expressed in liver; isoform B in smooth muscle
CC       cells and fibroblasts; isoform C in aortic endothelial cells, smooth
CC       muscle cells, fibroblasts, liver and lung, and isoform D in smooth
CC       muscle cells. {ECO:0000269|PubMed:10491078}.
CC   -!- SIMILARITY: Belongs to the peptidase M13 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01233, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D29683; BAA06152.1; -; mRNA.
DR   EMBL; AJ130826; CAB46528.1; -; mRNA.
DR   EMBL; AJ130827; CAB46529.1; -; mRNA.
DR   EMBL; D63795; BAA09864.1; -; mRNA.
DR   PIR; A53679; A53679.
DR   PIR; S66530; S66530.
DR   AlphaFoldDB; P42893; -.
DR   SMR; P42893; -.
DR   STRING; 10116.ENSRNOP00000062928; -.
DR   BindingDB; P42893; -.
DR   ChEMBL; CHEMBL2676; -.
DR   GuidetoPHARMACOLOGY; 1615; -.
DR   MEROPS; M13.002; -.
DR   GlyCosmos; P42893; 10 sites, No reported glycans.
DR   GlyGen; P42893; 10 sites.
DR   PhosphoSitePlus; P42893; -.
DR   SwissPalm; P42893; -.
DR   PaxDb; 10116-ENSRNOP00000062928; -.
DR   AGR; RGD:620293; -.
DR   RGD; 620293; Ece1.
DR   eggNOG; KOG3624; Eukaryota.
DR   InParanoid; P42893; -.
DR   PhylomeDB; P42893; -.
DR   BRENDA; 3.4.24.71; 5301.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   PRO; PR:P42893; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005769; C:early endosome; IDA:RGD.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0031982; C:vesicle; IDA:BHF-UCL.
DR   GO; GO:0033093; C:Weibel-Palade body; ISO:RGD.
DR   GO; GO:0004175; F:endopeptidase activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IMP:RGD.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:0060385; P:axonogenesis involved in innervation; ISO:RGD.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; IMP:RGD.
DR   GO; GO:0010815; P:bradykinin catabolic process; ISO:RGD.
DR   GO; GO:0010816; P:calcitonin catabolic process; ISO:RGD.
DR   GO; GO:0043583; P:ear development; ISO:RGD.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; ISO:RGD.
DR   GO; GO:0035050; P:embryonic heart tube development; ISO:RGD.
DR   GO; GO:0034959; P:endothelin maturation; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0042447; P:hormone catabolic process; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0016486; P:peptide hormone processing; ISO:RGD.
DR   GO; GO:0060037; P:pharyngeal system development; ISO:RGD.
DR   GO; GO:0043950; P:positive regulation of cAMP-mediated signaling; IMP:RGD.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IMP:RGD.
DR   GO; GO:0045745; P:positive regulation of G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0001921; P:positive regulation of receptor recycling; IMP:RGD.
DR   GO; GO:0016485; P:protein processing; IDA:RGD.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:RGD.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0035994; P:response to muscle stretch; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:1902287; P:semaphorin-plexin signaling pathway involved in axon guidance; ISO:RGD.
DR   GO; GO:0010814; P:substance P catabolic process; ISO:RGD.
DR   GO; GO:0097492; P:sympathetic neuron axon guidance; ISO:RGD.
DR   CDD; cd08662; M13; 1.
DR   Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 1.
DR   Gene3D; 1.10.1380.10; Neutral endopeptidase , domain2; 1.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR000718; Peptidase_M13.
DR   InterPro; IPR018497; Peptidase_M13_C.
DR   InterPro; IPR042089; Peptidase_M13_dom_2.
DR   InterPro; IPR008753; Peptidase_M13_N.
DR   PANTHER; PTHR11733:SF130; ENDOTHELIN-CONVERTING ENZYME 1; 1.
DR   PANTHER; PTHR11733; ZINC METALLOPROTEASE FAMILY M13 NEPRILYSIN-RELATED; 1.
DR   Pfam; PF01431; Peptidase_M13; 1.
DR   Pfam; PF05649; Peptidase_M13_N; 1.
DR   PRINTS; PR00786; NEPRILYSIN.
DR   SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1.
DR   PROSITE; PS51885; NEPRILYSIN; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Hydrolase; Membrane; Metal-binding; Metalloprotease; Protease;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix;
KW   Zinc.
FT   CHAIN           1..762
FT                   /note="Endothelin-converting enzyme 1"
FT                   /id="PRO_0000078221"
FT   TOPO_DOM        1..60
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        61..81
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        82..762
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          90..762
FT                   /note="Peptidase M13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   ACT_SITE        600
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   ACT_SITE        663
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   BINDING         599
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         603
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         659
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   CARBOHYD        158
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        179
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        202
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        262
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        308
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        354
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        375
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        531
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        624
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        643
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        91..96
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   DISULFID        114..747
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   DISULFID        122..707
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   DISULFID        177..427
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   DISULFID        636..759
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   VAR_SEQ         1..36
FT                   /note="MGSLRPPQGLGLQWSSFFLGKKGPGLTVSLPLLASS -> MRTVWPPLRAAL
FT                   AALGMSSYKRATLDEEDLVDSLSEGDVYPNG (in isoform B)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005505"
FT   VAR_SEQ         1..36
FT                   /note="MGSLRPPQGLGLQWSSFFLGKKGPGLTVSLPLLASS -> MMSSYKRATLDE
FT                   EDLVDSLSEGDVYPNG (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:8034569"
FT                   /id="VSP_005506"
FT   VAR_SEQ         1..36
FT                   /note="MGSLRPPQGLGLQWSSFFLGKKGPGLTVSLPLLASS -> METLRESVLHLA
FT                   LQMSSYKRATLDEEDLVDSLSEGDVYPNG (in isoform D)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005507"
FT   MUTAGEN         420
FT                   /note="C->S: Loss of dimerization."
FT                   /evidence="ECO:0000269|PubMed:8645169"
FT   MUTAGEN         600
FT                   /note="E->Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:8645169"
FT   MUTAGEN         659
FT                   /note="E->Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:8645169"
FT   MUTAGEN         724
FT                   /note="H->Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:8645169"
SQ   SEQUENCE   762 AA;  86126 MW;  D6B8253BC67CCAD8 CRC64;
     MGSLRPPQGL GLQWSSFFLG KKGPGLTVSL PLLASSLQVN FRSPRSGQRC WAARTSVEKR
     LVVLVTLLAA GLVACLAALG IQYRTRTPPV CLTEACVSVT SSILNSMDPT VDPCQDFFSY
     ACGGWIKANP VPDGHSRWGT FSNLWEHNQA IIKHLLENST ASASEAEKKA QVYYRACMNE
     TRIEELRAKP LMELIEKLGG WNITGPWAKD NFQDTLQVVT AHYRTSPFFS VYVSADSKNS
     NSNVIQVDQS GLGLPSRDYY LNKTENEKVL TGYLNYMVQL GKLLGGGDED SIRPQMQQIL
     DFETALANIT IPQEKRRDEE LIYHKVTAAE LQTLAPAINW LPFLNAIFYP VEINESEPIV
     VYDKEYLRQV STLINSTDKC LLNNYMMWNL VRKTSSFLDQ RFQDADEKFM EVMYGTKKTC
     LPRWKFCVSD TENNLGFALG PMFVKATFAE DSKNIASEII LEIKKAFEES LSTLKWMDED
     TRRSAKEKAD AIYNMIGYPN FIMDPKELDK VFNDYTAVPD LYFENAMRFF NFSLRVTADQ
     LRKAPNRDQW SMTPPMVNAY YSPTKNEIVF PAGILQAPFY TRSSPNALNF GGIGVVVGHE
     LTHAFDDQGR EYDKDGNLRP WWKNSSVEAF KQQTECMVQQ YNNYSVNGEP VNGRHTLGEN
     IADNGGLKAA YRAYQNWVKK NGAEQILPTL GLTSNQLFFL GFAQVWCSVR TPESSHEGLI
     TDPHSPSRFR VIGSLSNSKE FSEHFRCPLG SPMNPRHKCE VW
//
